SureTrader SPDR Advertisement SPDR Advertisement
Home > Boards > US Listed > Biotechs >

Novavax (NVAX)

NVAX RSS Feed
Add NVAX Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator LongRun8, TRUTH
Search This Board:
Last Post: 7/30/2015 8:36:59 AM - Followers: 129 - Board type: Free - Posts Today: 0

ABOUT NOVAVAX:

Novavax, Inc. (Nasdaq: NVAX) is a clinical-stage biopharmaceutical company creating recombinant protein nanoparticle vaccines to address a broad range of infectious diseases. The company is developing a portfolio of vaccine candidates targeting seasonal and pandemic influenza (H5N1), a vaccine designed to protect children and the elderly against respiratory syncytial virus (RSV), rabies and other candidates. In addition, the company is developing its vaccine candidates for worldwide commercialization including:

Our world-class scientific team is using VLP technology to tackle influenza viruses – including avian strains that have the potential to cause a pandemic outbreak. Our team has created vaccine candidates that are in various phases of clinical testing designed to protect against various circulating strains of pandemic influenza including H1N1 and H5N1, as well as seasonal influenza. Our recombinant nanoparticle protein micelle technology targeted at RSV has been tested in various preclinical studies and has now advanced into clinical testing.

Our vision is to control the spread of infectious diseases by using a unique single-use manufacturing system that allows for the rapid mass production of recombinant protein nanoparticle vaccines. Our goal is to be able to rapidly deliver a customized vaccine in the midst of a declared pandemic.
 


MANAGEMENT TEAM:

President and Chief Executive Officer
Stanley C. Erck

Senior Vice President, Research and Development
Gregory M. Glenn, M.D.

Senior Vice President, Manufacturing and Process Development
Timothy J. Hahn, Ph.D.

Senior Vice President, Chief Financial Officer and Treasurer
Barclay A. "Buck" Phillips

Senior Vice President, Business Development
Russell P. "Rip" Wilson

Vice President, Regulatory Affairs
Amy B. Fix

Vice President, Chief Medical Officer
Louis F. Fries III, M.D.

Vice President, Manufacturing
Mervyn L. Hamer

Vice President, General Counsel and Corporate Secretary
John A. Herrmann III, J.D.

Vice President, Process Development
Erica Shane, Ph.D.

Vice President, Vaccine Development
Gale Smith, Ph.D.

Vice President, Clinical Operations
D. Nigel Thomas, Ph.D.

 

CLINICAL-STAGE PIPELINE:

Novavax’s clinical program includes vaccine candidates designed to address infectious diseases worldwide. Using innovative virus-like particle (VLP) and recombinant nanoparticle technology, as well as new and efficient manufacturing approaches, the company produces vaccine candidates to combat diseases, with the goal of allowing countries to better prepare for and more effectively respond to rapidly spreading infections. Our clinical pipeline is shown below.

 
ADJUVANT PIPELINE:

 

 
CHARTS:



 


LINKS:

http://www.novavax.com/
http://finance.yahoo.com/q/h?s=NVAX
http://www.novavax.com/download/File/Interphex.pdf
http://www.sec.gov/cgi-bin/browse-edgar?company=Novavax&CIK=&filenum=&State=&SIC=&owner=include&action=getcompany
http://www.wipo.int/pctdb/en/wo.jsp?WO=2008061243

 
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NVAX
Current Price
Volume:
Bid Ask Day's Range
Wiki
NVAX News: Novavax Announces Positive Data From Phase 2 Trial of Quadrivalent Seasonal Influenza VLP 07/30/2015 08:31:07 AM
NVAX News: Updates on Biotechnology Industry Stocks -- ZIOPHARM Oncology, Novavax, Galena Biopharma, Sorrento Therapeutics, and Aegerion... 07/17/2015 09:25:00 AM
NVAX News: The Single Greatest Mistake You Can Make When Investing in Biotech 07/12/2015 02:02:02 PM
NVAX News: Why Novavax Shares Rocketed Higher By Nearly 25% in June 07/07/2015 01:02:02 PM
NVAX News: Statement of Changes in Beneficial Ownership (4) 06/22/2015 05:03:55 PM
PostSubject
#2119  Sticky Note **Novavax CEO: Vaccination Value / Mad Money / CNBC** TRUTH 02/19/15 09:05:49 AM
#2207   Novavax Announces Positive Data From Phase 2 Trial LongRun8 07/30/15 08:36:59 AM
#2206   Thanks. Please keep your ear to the wall. nypete 07/22/15 03:48:42 PM
#2205   New 52-week intraday high ($13.12) today. EOM. LongRun8 07/21/15 04:32:34 PM
#2204   Ebola trial results out! underdog150 07/21/15 08:49:18 AM
#2203   New 52-week closing high ($12.43) today. EOM. LongRun8 07/20/15 04:10:59 PM
#2202   New 52-week intraday high ($12.76) today. LongRun8 07/15/15 10:33:44 PM
#2201   New 52-week closing high ($12.18) today. LongRun8 07/14/15 04:02:11 PM
#2200   New 52-week intraday high ($12.44) today. LongRun8 07/10/15 05:26:40 PM
#2199   New 52-week intraday high ($12.17) and closing high LongRun8 07/09/15 04:36:51 PM
#2198   Loving the movement. TRUTH 07/09/15 04:21:21 PM
#2197   Hedge fund word is news release mon july volatility magnet 07/09/15 01:04:08 PM
#2196   Glad I added more yesterday stockwinner 07/09/15 09:44:45 AM
#2195   Novavax target raised to $18 ahead of vaccine underdog150 07/09/15 08:45:25 AM
#2194   It'll break through it tomorrow TOM611 07/07/15 04:49:33 PM
#2193   New 52-week closing high ($11.355) today. LongRun8 07/07/15 04:02:54 PM
#2192   It will this. Yearrt TOM611 07/05/15 08:36:43 PM
#2191   Didn't* stockwinner 07/02/15 04:56:16 PM
#2190   Did hit 15 :) as u predicted stockwinner 07/02/15 04:05:17 PM
#2189   Haha it was thanks stockwinner 06/30/15 06:12:18 PM
#2188   Apparently a good move. ;-) TRUTH 06/30/15 06:00:55 PM
#2187   The market tanked big time wow stockwinner 06/29/15 04:22:35 PM
#2186   I grabbed more at 10.50 :) stockwinner 06/29/15 09:45:50 AM
#2185   Nvax hits 15. This week. TOM611 06/29/15 08:24:54 AM
#2184   Haha am not short at all I am a stockwinner 06/28/15 07:31:58 PM
#2183   You either have this heavily shorted or you ThatBobGuy 06/28/15 07:07:49 PM
#2182   Bloodbath in market tomorrow NVAX to 10$ stockwinner 06/28/15 06:16:33 PM
#2181   40 millys worth bought after hours. Go. Nvax TOM611 06/28/15 05:55:23 PM
#2180   Four trial results projected to be released third LongRun8 06/25/15 09:02:33 AM
#2179   Very interesting indeed. TRUTH 06/24/15 08:47:13 PM
#2178   New 52-week intraday high ($11.45) and closing high LongRun8 06/24/15 04:12:05 PM
#2177   It lost the steam and will retrace a stockwinner 06/24/15 01:19:40 PM
#2176   $30 stockwinner 06/24/15 11:39:57 AM
#2175   Go to 16 soon cristianhuallpa 06/24/15 11:10:40 AM
#2174   New 52-week intraday high ($11.16) and closing high LongRun8 06/23/15 04:16:12 PM
#2173   So Strong, so Long! \o/ MRatt 06/23/15 12:08:25 PM
#2172   New 52-week intraday high ($10.00) and closing high LongRun8 06/22/15 09:07:07 PM
#2171   Heavy volume and great price action. Might LongRun8 06/22/15 10:19:08 AM
#2170   Looks like a very nice addition to the sarshee 06/18/15 04:53:05 PM
#2169   This is a very nice addition to the LongRun8 06/18/15 08:43:29 AM
#2168   Novavax Appoints Gail Boudreaux to Board LongRun8 06/18/15 08:40:35 AM
#2167   We broke through today like it wasn't even there TOM611 06/17/15 04:47:10 PM
#2166   $9 seems like a difficult resistance level to tttengy 06/17/15 10:08:18 AM
#2165   Well, now we know why those large blocks LongRun8 06/01/15 07:50:48 PM
#2164   Eom. Managers. Booking TOM611 05/29/15 09:26:41 AM
#2163   From what I have gleaned, market makers use LongRun8 05/28/15 10:14:17 PM
#2162   So if some "entity" wants to buy enough Juice Newton 05/28/15 06:27:27 PM
#2161   Usually that's an entity buying those shares. LongRun8 05/28/15 05:50:20 PM
#2160   Huge order at $8.70 big discount Juice Newton 05/28/15 05:14:26 PM
#2159   I can live with that analysis.... TRUTH 05/19/15 02:47:19 PM
#2158   Once a head phase 3 for any of TOM611 05/18/15 08:34:12 PM
PostSubject